Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

42,193 stories, page 502 of 704

Advanced search

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

BriaCell (BCTX) Expands Phase 3 Study with New Clinical Site

GuruFocusOriginal source

🌍Jul 16discoverynews.google.comTier 2 · Trade media

Racing Takeda, InnoCare reports TYK2 inhibitor win in phase 2 vitiligo trial

Fierce BiotechOriginal source

🇺🇰Jul 16Regulatorygov.ukTier 1 · Regulatory source

Care workforce pathway for adult social care

The care workforce pathway outlines the knowledge, skills, values and behaviours people need to work...

UK Department of Health and Social CareOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Manufacturer agreed for the M72 TB vaccine candidate, pending trial outcomes

wellcome.orgOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Electronic prescription service: the battle for nominations

The Pharmaceutical JournalOriginal source

🇺🇰Jul 16Regulatorygov.ukTier 1 · Regulatory source

JCVI publishes new recommendation to Government on adolescent MenB vaccination

The Department of Health and Social Care (DHSC) will consider the recommendation before a decision i...

UK Health Security AgencyOriginal source

🌍Jul 16discoverynews.google.comTier 2 · Trade media

Merck dives into cholesterol with first FDA approval for oral PCSK9 inhibitor

BioSpaceOriginal source

🌍Jul 16Industryuk-cpi.comTier 1 · Company source

CPI welcomes stakeholders to showcase Tees Valley's growing role in the UK's food innovation future

CPI (Healthcare Innovation)Original source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Newland Pharmaceutical Co., Ltd. Class A – SZSE:301277

TradingViewOriginal source

🌍Jul 16discoverynews.google.comTier 2 · Trade media

Pharmalittle: We're reading about Kalshi bets on clinical trials, a Merck cholesterol pill, and more

STATOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Kalshi launches biotech prediction markets pilot program

Kalshi NewsOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Biotech Venture Funding Roars Back

WSJOriginal source

🌍Jul 16discoverynews.google.comTier 2 · Trade media

FDA approves Merck’s oral PCSK9 drug, a first

STATOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Lilly to Acquire AtaiBeckley

Contract PharmaOriginal source

🇺🇰Jul 16Regulatorygov.ukTier 1 · Regulatory source

COVID-19 vaccination in autumn 2027: JCVI advice

Statement setting out advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the...

UK Department of Health and Social CareOriginal source

🇺🇰Jul 16Regulatorygov.ukTier 1 · Regulatory source

Plans for fair pay agreements in adult social care (easy read)

We want to know what you think about our plans for fair pay agreements in adult social care.

UK Department of Health and Social CareOriginal source

🇺🇰Jul 16Regulatorygov.ukTier 1 · Regulatory source

Fair pay agreement process in adult social care

Consultation about the fair pay agreement process in adult social care.

UK Department of Health and Social CareOriginal source

🇺🇰Jul 16Regulatorygov.ukTier 1 · Regulatory source

All-cause mortality surveillance

Seasonal excess all-cause mortality surveillance and heat and cold mortality monitoring reports from...

UK Health Security AgencyOriginal source

🇺🇰Jul 16Regulatorygov.ukTier 1 · Regulatory source

Flu vaccines 2027 to 2028: JCVI advice, 16 July 2026

Statement from the Joint Committee on Vaccination and Immunisation (JCVI) about vaccines for the 202...

UK Department of Health and Social CareOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

The deceptive advertisements masking drug dangers

Washington ExaminerOriginal source

🇫🇷Jul 16Regulatorya3p.orgTier 1 · Regulatory source

Hidden costs in Environmental Monitoring: Why Quality is more expensive than you think?

A3P FranceOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

What Does Vir Biotechnology's Astellas Deal Mean for Its Future

Kavout | AIOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Eli Lilly confirms rumors: Makes a bid for AtaiBeckley

medwatch.comOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

BriaCell Opens First Canadian Site - Sunnybrook - for Pivotal Phase 3 Trial in Metastatic Breast Cancer

Investing News NetworkOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Mumbai food safety crackdown: FDA suspends licences of Shalimar, Noor Mohammadi and Rehmania restaurants

MSNOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Lilly to Acquire AtaiBeckley in Up to $3.8 Billion Mental Health Deal

citybizOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Kalshi expands into biotech with clinical trial wagers By Investing.com

Investing.com NigeriaOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Kalshi expands into biotech with clinical trial wagers

Investing.comOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Pharma Pulse: CVS Credits TrumpRx to Deductibles, Germany Hikes Drug Rebates

Pharmaceutical CommerceOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Republican U.S. Senators Urge Acting Attorney General Todd to Protect Life, Counter What They Say Are ‘Dangerous’ Mail-Order Abortion Drugs

Sierra Sun TimesOriginal source

🌍Jul 16discoverynews.google.comTier 2 · Trade media

Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals

STATOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Life-changing MS drugs to stay on the PBS. So why are others under threat – and how is Trump involved?

The GuardianOriginal source

🇨🇦Jul 16Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

V-Loc™ 90 and 180 Suture Products

On 29-Jan-2026 during a quality inspection at a manufacturing site, a V-Loc 180 unit was found with...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Jul 16Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

StrykeFlow PS and AHTO

There has been an increased amount in reported complaints consistently describing leaking from the h...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Jul 16Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Solar™ GI

Under extended clinical use conditions (e.g., long-duration studies), moisture generated within the...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Jul 16Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

SEMA 3

When an ECG is aquired with DEFIGARD Touch 7 or ARGUS PRO LifeCare 3 with the newest software, there...

Health Canada Recalls and Safety AlertsOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Kalshi Will Offer Sports-Style Betting on Drug Trial Results

Bloomberg.comOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Grifols Trial Could Expand Treatment Options for 60,000 Patients

Stock TitanOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

H.C. Wainwright reiterates Axsome stock rating on FDA filing By Investing.com

Investing.com AustraliaOriginal source

🇺🇰Jul 16Researched.ac.ukTier 2 · Direct publisher

Elusive planet found after years of hide-and-seek

University of EdinburghOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Vegan PDRN Is Reshaping Regenerative Skincare as Biotech Alternatives Gain Momentum

BeautyMatterOriginal source

🌍Jul 16discoverynews.google.comTier 2 · Trade media

Eli Lilly to acquire psychedelics-focused biotech AtaiBeckley

STATOriginal source

🌍Jul 16discoverynews.google.comTier 2 · Trade media

Lilly buys AtaiBeckley for $2.8B upfront to challenge J&J for psychedelic mental health market

Fierce BiotechOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Sandoz reshapes leadership to capitalise on biosimilar golden decade

European Pharmaceutical ReviewOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Nature Medicine Features BriaCell Trial Among 11 That Will Shape Medicine

Stock TitanOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer

GlobeNewswireOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Russian reference standards centre expands into pharmaceutical wholesale and storage

Новости GxPOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Eli Lilly buys psychedelic biotech backed by Peter Thiel

Financial TimesOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Single-Use Sterile Bioprocessing Tools

Trend HunterOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Single-Use Sterile Bioprocessing Tools

Trend HunterOriginal source

🌍Jul 16Industryrelmada.comTier 1 · Company source

Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Relmada TherapeuticsOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

European Biotech Act Advances Biotechnology Innovation

EMJOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

How To Use Maharashtra FDA’s New AI Portal To Report Unsafe Food?

curlytales.comOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

FedEx Life Sciences launches to support pharmaceutical logistics

Logistics ManagerOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Moderna Trial Tests Cancer Therapy Encoding Seven Antigens

Stock TitanOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction

CNBCOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

AtaiBeckley’s BPL-003 Shows Months of Effects After 2-Hour Visits

Stock TitanOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions

PR NewswireOriginal source

🇺🇸Jul 16Industryinvestor.lilly.comTier 1 · Company source

Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions

Eli Lilly NewsOriginal source

🌍Jul 16discoverynews.google.comTier 2 · Trade media

Amylyx nears pivotal endocrine drug study readout

STATOriginal source